Expert Video - What is treatment failure and relapse in AML?
Dr. Jamile Shammo, an expert on acute myeloid leukemia (AML), explains what treatment failure and relapse in AML means, and describes its various forms. Treatment failure occurs when your AML treatment is not successful in eliminating all the leukemia from your bone marrow after initial therapy (induction chemotherapy). It could also mean that the leukemia came back (relapsed) after being well controlled after chemotherapy and entering a state known as remission.
Share with family and friends:
Click here to take our SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about AML which will help other patients, caregivers and families.
This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.
This activity is supported by educational grants from AbbVie, Acceleron, Bristol-Myers Squibb, Celgene Corporation, Daiichi Sankyo, Jazz Pharmaceuticals and Takeda Oncology.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.